SONENDO INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SONENDO INC and buy or sell other stocks, ETFs, and their options commission-free!

About SONX

Sonendo, Inc. is a medical technology company, which developed and manufactures the GentleWave System to treat tooth decay. It operates through the Product and Software segments. 

CEO
Bjarne Bergheim
CEOBjarne Bergheim
Employees
216
Employees216
Headquarters
Laguna Hills, California
HeadquartersLaguna Hills, California
Founded
2006
Founded2006
Employees
216
Employees216

SONX Key Statistics

Market cap
137.95K
Market cap137.95K
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
2.36K
Average volume2.36K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$80.00
52 Week high$80.00
52 Week low
$1.00
52 Week low$1.00

Stock Snapshot

As of today, SONENDO INC(SONX) shares are valued at $0.33. The company's market cap stands at 137.95K, with a P/E ratio of -0.03.

On 2026-04-20, SONENDO INC(SONX) stock opened at —, reached a high of —, and a low of —.

SONENDO INC(SONX) shares are trading with a volume of 0, against a daily average of 2.36K.

In the last year, SONENDO INC(SONX) shares hit a 52-week high of $80.00 and a 52-week low of $1.00.

In the last year, SONENDO INC(SONX) shares hit a 52-week high of $80.00 and a 52-week low of $1.00.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.